Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Prostate Cancer Prostatic Dis ; 22(2): 303-308, 2019 05.
Article in English | MEDLINE | ID: mdl-30385836

ABSTRACT

BACKGROUND: Transurethral resection of the prostate is the most commonly performed procedure for the management of benign prostatic obstruction. However, little is known about the effect surgical duration has on complications. We assess the relationship between operative time and TURP complications using a modern national surgical registry. METHODS: We queried the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) from 2006 to 2016 for patients undergoing TURP. Patients were separated into five groups based on operative time: 0-30 min, 30.1-60 min, 60.1-90 min, 90.1-120 min, and greater than 120 min. Standard statistical analysis, including multivariate regression, was performed to determine factors associated with complications. RESULTS: 31,813 patients who underwent TURP were included. The overall complication rate was 9.0% and increased significantly with longer surgical duration (p < 0.001). Longer operative time was associated with a greater risk of postoperative sepsis or shock, transfusion, reoperation, and deep vein thrombus or pulmonary embolism. Longer surgical duration was associated with increased odds of any complication and, specifically, blood transfusion after controlling for age, race, comorbidities, American Society of Anesthesia (ASA) class, type of anesthesia administered, and trainee involvement. The adjusted risk of each of the above complications remained significantly increased for surgeries lasting longer than 120 min. CONCLUSIONS: As surgical duration increases, there is a significant increase in the rate of complications after TURP. These data demonstrate that this procedure is safest when performed in under 90 min.


Subject(s)
Operative Time , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Prostatic Diseases/complications , Prostatic Diseases/epidemiology , Transurethral Resection of Prostate/adverse effects , Aged , Aged, 80 and over , Comorbidity , Health Care Surveys , Humans , Male , Middle Aged , Prostatic Diseases/surgery , Quality Improvement , Quality of Health Care , Registries , Risk Factors , Transurethral Resection of Prostate/methods , Transurethral Resection of Prostate/statistics & numerical data , United States/epidemiology
2.
Radiol Clin North Am ; 56(2): 187-196, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29420975

ABSTRACT

The diagnosis and management of prostate cancer have substantially changed over the last 3 decades. Serum prostate-specific antigen (PSA) was adopted for screening in the 1990s after it was found to be a sensitive indicator of disease. Because of a lack of specificity for significant disease, indiscriminate PSA testing led to overdiagnosis and overtreatment. Several biomarkers have been developed that are superior to PSA in stratifying a man's risk for harboring potentially lethal prostate cancer.


Subject(s)
Early Detection of Cancer/methods , Mass Screening/methods , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Biomarkers/blood , Humans , Male , Sensitivity and Specificity
3.
Urol Oncol ; 36(5): 237.e19-237.e24, 2018 May.
Article in English | MEDLINE | ID: mdl-29395954

ABSTRACT

PURPOSE: Patients on hemodialysis have an increased risk of developing advanced stage bladder cancer. They also have a significant risk of noncancer-related mortality. Radical cystectomy (RC) is the standard of care for nonmetastatic muscle-invasive bladder cancer, however little is known regarding outcomes in this population. MATERIALS AND METHODS: The United States Renal Disease System database was used to identify all patients on hemodialysis who underwent RC for bladder cancer in the United States between 1984 and 2013. A total of 985 patients were identified for analysis. Perioperative outcomes were evaluated. Competing risks analysis was used to estimate overall and cancer-specific mortality along with factors associated with death. RESULTS: Median hospital length of stay was 10 days and 43.1% of patients experienced a complication. Mortality within 30 days was 9.3%. Overall mortality at 1, 3, and 5 years was 51.7%, 77.3%, and 87.9%, respectively. Cancer-specific mortality at 1, 3, and 5 years was 12.3%, 18.4%, and 19.7%, respectively. Age, diabetes, and cerebrovascular disease were independently associated with overall mortality, while performance of urinary diversion was associated with a protective effect. Active smoking was the sole risk factor for cancer-specific mortality. CONCLUSIONS: RC in dialysis patients is associated with significant morbidity and mortality, with less than 15% overall survival at 5 years. Older patients, and those with a history of diabetes or cerebrovascular disease, are at an increased risk of mortality.


Subject(s)
Cystectomy/adverse effects , Perioperative Care , Postoperative Complications/mortality , Renal Dialysis/mortality , Urinary Bladder Neoplasms/surgery , Aged , Databases, Factual , Female , Follow-Up Studies , Humans , Length of Stay , Male , Morbidity , Postoperative Complications/etiology , Prognosis , Risk Factors , Survival Rate
4.
Urol Clin North Am ; 44(4): 597-609, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29107276

ABSTRACT

An increasing proportion of men are undergoing radical prostatectomy for locally advanced prostate cancer. More than half of men with adverse pathologic features are expected to experience disease recurrence within 10 years. This article discusses the use of postoperative radiation therapy to decrease this risk. Evidence from 3 randomized trials and multiple retrospective studies indicates that either adjuvant or salvage radiation improve biochemical progression-free survival and may improve overall survival. Novel imaging and genomic analysis can improve patient selection for either modality, however current tests are unable to identify all patients who may benefit from additional local therapy.


Subject(s)
Neoplasm Grading , Neoplasm Recurrence, Local/radiotherapy , Patient Selection , Prostatectomy , Prostatic Neoplasms/therapy , Salvage Therapy/methods , Humans , Male , Prostatic Neoplasms/diagnosis , Radiotherapy, Adjuvant
5.
Urol Oncol ; 35(11): 659.e13-659.e19, 2017 11.
Article in English | MEDLINE | ID: mdl-28778584

ABSTRACT

INTRODUCTION: Radical cystectomy (RC) is the standard of care for invasive nonmetastatic bladder cancer. Unfortunately, it is a complex procedure and more than half of patients experience a complication. A number of efforts to reduce perioperative morbidity have been made, including alterations in pain management, antibiotics, diet advancement, and anticoagulation. Many of these changes in management have been studied with favorable results; however, it is not clear whether complication rates following RC have improved in recent years. With this in mind we sought to evaluate current temporal trends in postoperative complication rates following RC using a large national dataset. MATERIALS AND METHODS: Using the National Surgical Quality Improvement Program participant use files from 2010 to 2015, we identified patients undergoing RC using current procedural terminology codes. Demographic information as well as 30-day complications, length of stay (LOS), readmission and death were compared according to year of operation using univariable and multivariable analysis. RESULTS: Over the 6 year period analyzed, 6,510 patients were identified for analysis. Age and comorbidity were similar across the study period. A robotic approach was used in 5.8% of the entire cohort which did not differ among years. A total of 15.9% of patients underwent a continent urinary diversion, with a trend toward decreased use in recent years, 31.5% of patients experienced a complication and this did not differ significantly among years, and 40.7% of patients required a blood transfusion overall with a trend toward decreased use. LOS decreased over time from 10.6 days in 2010 to 9.2 days in 2015 (P<0.01) whereas readmissions increased slightly over the time period to 21.4% in 2015 (P<0.01). CONCLUSIONS: RC remains a procedure associated with high morbidity. In the recent era of enhanced recovery protocols, complication rates have not changed significantly, however, there has been a consistent decline in LOS and use of blood transfusion.


Subject(s)
Cystectomy/methods , Databases, Factual/statistics & numerical data , Quality Improvement/statistics & numerical data , Urinary Bladder Neoplasms/surgery , Aged , Aged, 80 and over , Comorbidity , Female , Humans , Length of Stay , Male , Middle Aged , Morbidity , Postoperative Complications/epidemiology , Quality Improvement/trends , United States/epidemiology
6.
J Endourol ; 31(7): 661-665, 2017 07.
Article in English | MEDLINE | ID: mdl-28537436

ABSTRACT

OBJECTIVES: To compare outcomes and survival of open-, robotic-, and laparoscopic nephroureterectomy (ONU, RNU, LNU) using population-based data. METHODS: Using the National Cancer Database, we identified patients who underwent nephroureterectomy for localized upper tract urothelial carcinoma between 2010 and 2013. Demographic and clinicopathologic characteristics were compared among the three operative approaches. Multivariate regression analyses were used to determine the impact of approach on performance of lymphadenectomy (LND), positive surgical margins (PSM), and overall survival (OS). RESULTS: In total, there were 9401 cases identified for analysis, including 3199 ONU (34%), 2098 RNU (22%), and 4104 LNU (44%). From 2010 to 2013, utilization of RNU increased from 14% to 30%. On multivariate analysis, LND was more likely in RNU (odds ratio [OR] 1.52; p < 0.01) and less likely in LNU (OR 0.77; p < 0.01) compared with ONU. RNU was associated with decreased PSM compared with ONU (OR = 0.73; p = 0.04). After adjusting for other factors, OS was not significantly associated with surgical approach. CONCLUSIONS: RNU utilization doubled over the study period. While RNU was associated with greater likelihood of LND performance as well as lower PSM rates when compared with ONU and LNU, surgical approach did not independently affect OS.


Subject(s)
Carcinoma, Transitional Cell/surgery , Laparoscopy , Nephroureterectomy/methods , Urologic Neoplasms/surgery , Aged , Female , Humans , Laparoscopy/mortality , Lymph Node Excision/statistics & numerical data , Male , Margins of Excision , Middle Aged , Multivariate Analysis , Odds Ratio , Robotic Surgical Procedures , Survival Analysis , Ureter/surgery , Urologic Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...